Decide at what price you'd be comfortable buying and we'll help you stay ready.
After earlier revenue growth, the top line contracted in the latest two annual periods, while gross profit did not cover operating expenses. Operating cash flow and free cash flow remained negative across the supplied annual history; positive net income in 2024 reflected business-sale gains rather than sustained earnings.
The 2025 results retained the established loss-making, cash-consuming profile but showed further revenue contraction and a return to net loss after 2024’s sale-gain-supported profit. This points to deterioration in scale, not a demonstrated shift to a profitable operating model.
Whether pro forma ARR and organic subscription revenue stabilize after the disclosed divestitures and customer-retention pressures.
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| (51.3m) | (109.4m) | (218.3m) | (115.5m) | 9.5m | (65.2m) | |
| 11.5m | 16.4m | 20.8m | 28.7m | 19.9m | 18m | |
| (2.3m) | (6.6m) | (3.1m) | 72k | (162k) | (189k) | |
| 1m | 1m | 38.1m | 27.1m | 18m | 14.8m | |
| 21.7m | 63.5m | 145m | 61.4m | (30.7m) | 40.7m | |
| 54k | 233k | 55k | 55k | 274k | 1.2m | |
| 9m | 4.7m | 35.2m | 20.7m | 14.7m | 9.7m | |
| 3.2m | (848k) | (17.1m) | (10.2m) | (3.9m) | (4.6m) | |
| (17.2m) | (37m) | (72.6m) | (35.5m) | (5.3m) | ||
| (5.5m) | (5.6m) | (11.4m) | (7.9m) | (8.9m) | ||
| 0 | (43.6m) | 1.1m | (12.4m) | 98.1m | 46.9m | |
| (5.5m) | (49.2m) | (10.2m) | (20.3m) | 89.2m | 39.7m | |
| 247k | 13.1m | 179.9m | 684k | 474k | 276k | |
| 60.4m | 61.2m | (23.1m) | 11.4m | (64.5m) | (27.8m) | |
| — | — | (45.2m) | 0 | (7.4m) | (5.3m) | |
| 60.7m | 74.3m | 111.5m | 12.1m | (71.4m) | (32.8m) | |
| (77k) | (76k) | (449k) | (189k) | (284k) | 64k | |
| 37.9m | (12m) | 28.2m | (43.9m) | 12.2m | (4.5m) | |
| (22.7m) | (42.6m) | (84m) | (43.4m) | (14.2m) |
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more